Goldman: A Vaccine Could Hurt Investors

Goldman: A Vaccine Could Hurt Investors

over 3 years ago2 mins

Mentioned in story

A coronavirus cure might make us immune to one of the most devastating pandemics the world’s ever seen, but a recent report by Goldman Sachs suggests it could also leave some investors feeling a little peaky 🤒

What does this mean?

The pandemic’s been ushering investors toward the relative safety of bonds, as well as to big US tech stocks that have benefited from the global lockdowns. But Goldman’s now warned that once a vaccine eliminates coronavirus worries, investors might actually ditch those assets 💉 In bonds’ case, that’s because a vaccine that drives economic growth, inflation, and, eventually, a rise in interest rates will reduce the relative value of their fixed payments. Tech stocks, meanwhile, mightn’t look as attractive as the “cyclical” stocks that stand to benefit more from an economic recovery.

Daily Brief Image

Why should I care?

Investors may be reluctant to prepare for a “rotation” that might never actually happen, which is why Goldman’s analysts recommend they hedge their bets using options. For a small upfront fee, you can purchase the right to buy or sell stocks at a pre-agreed cost when they hit a certain “strike” price. So you could buy a “call” (i.e. the right to buy stocks) with a higher strike price than currently, as well as a separate “put” (i.e. the right to sell) at a lower strike price than currently 📊 That should allow you to benefit whether shares keep rising or drop significantly.

Another spanner in the works could be November’s US election: if the Democrats win big – which investors think is likely – Goldman reckons the risk of a trade war will fall and the risk of higher taxes will rise 🌍 That could benefit emerging markets’ stocks – though given how uncertain they can be, options might help there too.

Daily Brief Image
Finimize

BECOME A SMARTER INVESTOR

All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG